Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(10 sites)
United States
Mayo Clinic Arizona, Scottsdale, Arizona City of Hope Medical Foundation, Duarte, California University of Southern California, Los Angeles, California University of Colorado Anschutz Medical Campus, Aurora, Colorado Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois University of Michigan, Ann Arbor, Michigan Barbara Ann Karmanos Cancer Institute Wayne State University, Detroit, Michigan Columbia University, New York, New York University of Pittsburgh Medical Center (UPMC), Pittsburgh, Pennsylvania The University of Texas MD Anderson Cancer Center, Houston, Texas